Evidence map›Paper›PMID 40164730›Full record

ArticleEuropean journal of human genetics : EJHG2025

DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.

Milou G P Kennis, Dmitrijs Rots, Arjan Bouman, Charlotte W Ockeloen, Caroline Boelen, Carlo L M Marcelis, Bert B A de Vries, Mariet W Elting, Quinten Waisfisz, Mohnish Suri and 18 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. The Great Escape: A Case Series onThe Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2026
    Article
  2. A massively parallel reporter assay ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Genomic medicine in full bloom: a summer farewell issue.European journal of human genetics : EJHG · 2025
    Article
  9. Role of DEAD/DEAH-box helicases in immunity, infection and cancers.Cell communication and signaling : CCS · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Milou G P KennisDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands. milou.kennis@radboudumc.nl.ORCID 0000-0002-2432-5438
Dmitrijs RotsDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.
Arjan BoumanDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Charlotte W OckeloenDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0003-0329-1520
Caroline BoelenDepartment of Pediatrics, Admiraal De Ruyter Ziekenhuis, Goes, Zeeland, The Netherlands.
Carlo L M MarcelisDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.
Bert B A de VriesDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0002-0000-2917
Mariet W EltingDepartment of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
Quinten WaisfiszDepartment of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
Mohnish SuriDepartment of Clinical Genetics, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Esperanza Font-MontgomeryDepartment of Pediatrics/Genetics/Metabolism Disorders, Children's Hospital of Michigan, Detroit, MI, USA.
Dawn S PeckDepartment of Pediatrics, University of Missouri School of Medicine, Columbia, MO, USA.
Deirdre E DonnellyNorthern Ireland Regional Genetics Centre, Belfast Health and Social Care Trust, Belfast, Northern Ireland.
R Curtis RogersGreenwood Genetic Center, Greenwood, SC, USA.
Ruth RichardsonNorthern Genetics Service, Newcastle upon Tyne hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Roseline CaumesCHU Lille, Clinique de génétique Guy Fontaine, F-, 59000, Lille, France.
Boris ChaumetteUniversité Paris Cité, Institute of Psychiatry and Neurosciences of Paris (INSERM U1266), GHU Paris Psychiatrie et Neurosciences, Paris, France.
Cécile LouveauUniversité Paris Cité, Institute of Psychiatry and Neurosciences of Paris (INSERM U1266), GHU Paris Psychiatrie et Neurosciences, Paris, France.
Suzanne C E H SalleveltPaediatric and Reproductive Genetics Unit, Women's and Children's Hospital, Adelaide, SA, Australia.
Saskia M MaasDepartment of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
Jeroen J SmitsDepartment of Human Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-4241-0900
Mieke M van HaelstDepartment of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands.ORCID 0000-0002-7519-0246
Rebecca J LevyNeurology and Neurological Sciences, Division of Child Neurology, Stanford University and Lucile Packard Children's Hospital, Palo Alto, California, USA.
Helen StewartOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Bart L LoeysDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0003-3703-9518
Rolph PfundtDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.
Tjitske KleefstraDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands.
Lot Snijders BlokDepartment of Human Genetics, Radboudumc, Nijmegen, The Netherlands. lot.snijdersblok@radboudumc.nl.ORCID 0000-0002-9825-3625

Funding

ZonMw (Netherlands Organisation for Health Research and Development) 10250022110003ZonMw (Netherlands Organisation for Health Research and Development) 91718310
6 · The paper itself

Abstract

DDX3X-related neurodevelopmental disorder is one of the most common monogenic causes of intellectual disability in females, with currently >1000 females diagnosed worldwide. In contrast, reports on affected males with DDX3X variants are scarce. The limited knowledge on this X-linked disorder in males hinders the interpretation of hemizygous DDX3X variants in clinical practice. In this study, we present a new cohort of 19 affected males (from 17 unrelated families) with (possibly) disease-causing DDX3X variants, for whom we collected clinical and molecular data. Additionally, we reviewed the existing literature on 13 males with DDX3X variants. The phenotype in males is diverse, including intellectual disability, speech/language delays, behavioural challenges and structural brain abnormalities. The vast majority of males have missense variants, including two recurrent variants (p.(Arg351Gln) and p.(Arg488Cys)). No truncating variants have been reported, consistent with the presumed embryonic lethality of complete loss-of-function of DDX3X in males. In our novel cohort, 6/17 variants are de novo in the affected male and 3/17 variants are de novo in the mother. This study provides significant insights in the genetic and phenotypic spectrum of males with DDX3X variants, by presenting the data of a combined cohort (n = 32) of novel and published individuals. Our data show that variants in DDX3X can cause an X-linked neurodevelopmental disorder in males, with unaffected or mildly affected carrier females. These findings will aid the interpretation of hemizygous missense variants in DDX3X and can guide clinical management and counselling, in particular with regard to recurrence risks in the respective families.

Indexed as

DEAD-box RNA HelicasesNeurodevelopmental DisordersAdolescentAdultChildChild, PreschoolFemaleHumansMaleMutation, MissensePhenotypeDDX3X protein, humanDEAD-box RNA Helicases

Identifiers

PMID40164730
PMCPMC12322063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.